DEPO Wins Patent Suit, EBS Surges On BARDA Funding, REGN's Eylea Combo Fails

Shares of Depomed Inc. (DEPO) touched a new 52-week high on Friday, thanks to the patent infringement suit related to NUCYNTA franchise going in favor of the company.

from RTT - Biotech http://ift.tt/2dApqPV
via IFTTT